SEC Form 4 · accession 0001179110-15-009362
ALDER BIOPHARMACEUTICALS INC · ALDR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
SRB Associates IX L.P.
10% Owner
Sevin Rosen Fund IX L.P.
10% Owner
Sevin Rosen IX Affiliates Fund L.P.
10% Owner
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 6:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001423824
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jun 4, 2015 | J | 2,024,483 | $0.00 | D | 2,024,483 | I | See Footnote (2) |
| Common StockF3 | Jun 4, 2015 | J | 46 | $0.00 | A | 46 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a pro rata in-kind distribution, without additional consideration, of 1,973,885 shares of Common Stock of the Issuer by Sevin Rosen Fund IX L.P. and 50,552 shares of Common Stock of the Issuer by Sevin Rosen IX Affiliates Fund L.P.
- F2Total Common Shares of 2,024,483 represents 46 shares owned directly by SRB Associates IX L.P. ("SRBAIX"), 1,973,885 shares owned directly by Sevin Rosen Fund IX L.P. ("SRFIX") and 50,552 shares owned directly by Sevin Rosen IX Affiliates Fund L.P. ("SRIX AFF"). SRBAIX is the general partner of SRFIX and SRIX AFF, and in that capacity has shared voting and dispositive power over such shares. SRBAIX disclaims beneficial ownership of such shares except to the extent of its pecuniary interest.
- F3Represents the receipt of shares of Common Stock of the Issuer by virtue of the pro rata in-kind distribution, without additional consideration, of Common Stock of the Issuer. Shares are held directly by SRBAIX.